Application value of SARS-CoV-2 IgG and IgM antibodies in diagnosis and treatment of new coronavirus pneumonia
Special Reports|更新时间:2026-01-09
|
Application value of SARS-CoV-2 IgG and IgM antibodies in diagnosis and treatment of new coronavirus pneumonia
Journal of Third Military Medical UniversityVol. 42, Issue 15, Pages: 1489-1494(2020)
作者机构:
1.400016 重庆, 重庆医科大学附属第一医院呼吸与危重症医学科
2.404000 重庆, 重庆市三峡中心医院检验科
作者简介:
基金信息:
the Special Project of Emergency Scientific Research for Infection and Prevention for SARS-CoV-2 of Chongqing(KYYJ202006);the Fourth Batch of "Special Tackling Projects of Emergency Science and Technology for New Coronavirus Epidemic" of Chongqing Science and Technology Committee(CSTC2020JSCX-FYZX0235)
Qianfang HU, Xiaohui WANG, Zhi AO, et al. Application value of SARS-CoV-2 IgG and IgM antibodies in diagnosis and treatment of new coronavirus pneumonia[J]. Journal of Third Military Medical University, 2020, 42(15): 1489-1494.
DOI:
Qianfang HU, Xiaohui WANG, Zhi AO, et al. Application value of SARS-CoV-2 IgG and IgM antibodies in diagnosis and treatment of new coronavirus pneumonia[J]. Journal of Third Military Medical University, 2020, 42(15): 1489-1494. DOI: 10.16016/j.1000-5404.202003186.
Application value of SARS-CoV-2 IgG and IgM antibodies in diagnosis and treatment of new coronavirus pneumonia
To explore the application value of chemiluminescence detection of SARS-CoV-2 IgM/IgG antibodies in the adjuvant diagnosis and treatment of coronavirus disease 2019 (COVID-19).
Methods
2
A total of 208 COVID-19-confirmed patients admitted in the Acute Pneumonia Section of Chongqing Three Gorges Central Hospital from January 23 to March 3
2020 were recruited and served as the confirmed group
and another 208 cases
including 158 non-COVID-19 patients from other departments and 50 health volunteers as blood donors were subjected as the control group. Chemiluminescence assay was used for detection of the antibodies.
Results
2
The results showed that the clinical sensitivity
specificity
positive predictive value
and negative predictive value for SARS-CoV-2 IgG antibody were 85.7%
99.0%
98.8%
and 87.6%
respectively. While the above values for SARS-CoV-2 IgM antibody were 66.5%
98.0%
97.1%
and 75.0%
respectively. And these values were 89.6%
96.8%
97.3%
and 87.9%
respectively
when the 2 antibodies combined together. There was no statistical difference in the detection rate of SARS-CoV-2 IgG and IgM antibodies. The average detection time from the date of onset was 10.8 (10.8±4.1) d in the severe group
statistically earlier than that in the mild group [13.3 (13.3±6.4) d
P
=0.017
]
. The median detection time of the IgG negative group was 7.0 (5.0~12.0) d after onset
earlier than 13.5 (10.0~17.0) d of the IgG positive group
with statistical difference (
P
=0.000 1); while
the median time of the IgM negative group was 11.0 (6.0~16.0) d after onset
earlier than 14.0 (10.0~17.0) d in the IgG positive group (
P
=0.016).
Conclusion
2
Chemiluminescence assay for detection of SARS-CoV-2 IgM and IgG antibodies has good specificity and sensitivity
and can help diagnose COVID-19
by making up the shortcomings of viral nucleic acid test. The detection time is the main factor affecting the results of antibody test
and early detection of SARS-CoV-2 IgM/IgG antibodies may indicate a more serious illness.
关键词
Keywords
references
ZHU N, ZHANG D Y, WANG W L, et al . A novel coronavirus from patients with pneumonia in China, 2019[J ] . N Engl J Med, 2020, 382(8): 727-733. DOI:10.1056/NEJMoa2001017.
LU H Z, STRATTON C W, TANG Y W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle[J]. J Med Virol, 2020, 92(4): 401-402. DOI:10.1002/jmv.25678.
HUANG C L, WANG Y M, LI X W, et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J ] . Lancet, 2020, 395(10223): 497-506. DOI:10.1016/S0140-6736(20)30183-5
[General Office of National Health Commission, Administration Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment plan of novel coronavirus pneumonia(7th Ed)[EB/OL ] .[2020-03-04 ] . https://so.m.sm.cn/c/s/m.vodjk.com/mip/a/1631009.shtml https://so.m.sm.cn/c/s/m.vodjk.com/mip/a/1631009.shtml .
CATHARINE I P, HILARY D M, ANTHONY S F. Coronavirus infections—more than just the common cold[J]. JAMA, 2020, 323(8):707-708. DOI:10.1001/jama.2020.0757.
CHEN D B, XU W X, LEI Z Y, et al . Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report[J ] . Int J Infect Dis, 2020, 93: 297-299. DOI:10.1016/j.ijid.2020.03.003.
XU W Z, LI J, HE X Y, et al . Diagnostic value of combined detection of serum 2019 new coronavirus IgM and IgG antibodies in new coronavirus infection[J ] . Chin J Lab Med, 2020, 43(3): 230-233. DOI: 10.3760/cma.j.issn.1009-9158.2020.03.007.
LI G, CHEN X J, XU A L. Profile of specific antibodies to the SARS-associated coronavirus[J]. N Engl J Med, 2003, 349(5): 508-509. DOI:10.1056/NEJM200307313490520.
ZHOU P, YANG X L, WANG X G, et al . A pneumonia outbreak associated with a new coronavirus of probable bat origin[J ] . Nature, 2020, 579(7798): 270-273. DOI:10.1038/s41586-020-2012-7.